Abbott’s (ABT) Q4 Earnings and Revenues Beat Estimates Posted byZacks Equity Research January 26, 2022 Leave a comment on Abbott’s (ABT) Q4 Earnings and Revenues Beat Estimates Abbott’s (ABT) COVID-19 testing-related sales in Q4 increased on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.